#CVS Chorionic Villus Sampling
Explore tagged Tumblr posts
Text
CVS Chorionic Villus Sampling | Mothers and Fetuses Group
A prenatal test called CVS Chorionic Villus Sampling helps in the identification of genetic anomalies in a growing fetus. We provide this test to pregnant moms who are at a higher risk for chromosomal or genetic problems at Mother and Fetuses Medical Center Hospital. A small sample of tissue from the placenta, which includes the fetus' genetic material, is taken during the surgery. Afterwards, in a lab, this tissue is examined to look for any anomalies.
Between the 10th and 13th week of pregnancy is the traditional time for a CVS, which can provide information regarding genetic diseases such Down syndrome, cystic fibrosis, and sickle cell anemia. Although CVS is a very accurate test, there is a very little chance of miscarriage. To assist you in making an informed choice, our team of knowledgeable physicians and genetic counselors will go over the procedure's advantages and disadvantages with you. We recommend scheduling a consultation with our staff at Mother and Fetuses Medical Center Hospital if you are thinking about CVS. In order to guarantee the greatest outcome for you and your child, we are devoted to provide individualized and sensitive treatment.
0 notes
Text
Avoiding Down Syndrome: What Every Expecting Parent Needs to Know
Welcoming a child into the world is a life-changing event for parents. While most pregnancies progress without complications, genetic disorders such as Down syndrome are a concern for many expecting parents. Down syndrome, a genetic condition caused by an extra chromosome 21, can affect the physical and cognitive development of a child. Although it cannot always be prevented, advancements in medical technology and prenatal care allow parents to reduce risks and make informed decisions. This article explores ways to avoid Down syndrome, the role of gender selection, and how genetic testing empowers families for healthier pregnancies.
Understanding Down Syndrome and Its Causes
1. What Is Down Syndrome?
Down syndrome, also called trisomy 21, is a chromosomal abnormality that occurs when a baby has an extra copy of chromosome 21. This genetic condition leads to developmental delays, intellectual disabilities, and distinct physical features, such as low muscle tone and unique facial characteristics.
2. Causes of Down Syndrome
The primary cause of Down syndrome/متلازمة الداون is an error during the division of reproductive cells, resulting in the extra chromosome. The likelihood of this genetic condition increases with maternal age, especially for women over 35. However, it can occur in pregnancies at any age.
How to Reduce the Risk of Down Syndrome
While it’s impossible to eliminate all risks, certain measures can help parents minimize the chances of having a child with Down syndrome.
1. Genetic Testing
One of the most effective ways to reduce the risk is through genetic testing. Prenatal screenings and diagnostic tests help identify chromosomal abnormalities early in pregnancy.
Non-Invasive Prenatal Testing (NIPT): A blood test that analyzes fetal DNA in the mother’s bloodstream to detect chromosomal abnormalities.
Amniocentesis and Chorionic Villus Sampling (CVS): Diagnostic procedures that examine fetal cells for genetic conditions, providing accurate results.
2. Family Planning at a Younger Age
As maternal age is a significant factor, planning pregnancies earlier in life can reduce the risk of chromosomal abnormalities.
3. Preimplantation Genetic Testing (PGT)
For couples using assisted reproductive technologies like in-vitro fertilization (IVF), preimplantation genetic testing is a valuable tool. PGT screens embryos for chromosomal abnormalities before implantation, ensuring that only healthy embryos are used in the IVF process.
The Role of Gender Selection in Family Planning
Gender selection, a method often associated with family balancing, can also play a role in reducing genetic risks. While it does not directly prevent Down syndrome, it is part of a comprehensive fertility approach.
1. How Gender Selection Works
Through advanced reproductive technologies, doctors can identify the sex of an embryo before implantation during IVF. Gender selection is often combined with preimplantation genetic testing to ensure the healthiest embryos are chosen.
2. Family Balancing and Genetic Health
Some parents opt for gender selection as part of their family planning to balance their household while prioritizing genetic health. By selecting healthy embryos, the chances of chromosomal abnormalities, including Down syndrome, are significantly reduced.
3. Ethical Considerations
While gender selection is legal in many countries, ethical considerations should be taken into account. It is essential for parents to prioritize genetic health and consult with medical professionals about the best options.
The Importance of Genetic Counseling
Genetic counseling is a vital resource for families who want to understand their risks and explore preventive measures.
1. Assessing Risk Factors
A genetic counselor evaluates personal and family medical histories to estimate the likelihood of chromosomal abnormalities, including Down syndrome.
2. Explaining Testing Options
Counselors provide guidance on the types of genetic tests available, helping parents choose the most appropriate option for their situation.
3. Supporting Informed Decisions
Genetic counseling empowers parents to make informed decisions about their reproductive options, including IVF, PGT, and prenatal testing.
How Technology Empowers Parents to Avoid Down Syndrome
Medical advancements have revolutionized prenatal care, giving parents more control over their pregnancies.
1. IVF and Genetic Screening
In cases where natural conception carries higher risks, IVF combined with genetic screening ensures a healthy start for the baby.
2. Early Detection Through Testing
Modern prenatal tests, such as NIPT, provide early and non-invasive detection of Down syndrome, allowing parents to plan accordingly.
3. Healthier Pregnancy Outcomes
Technologies such as PGT and gender selection contribute to healthier pregnancies by reducing the chances of chromosomal abnormalities.
Coping with the Diagnosis of Down Syndrome
Despite preventive measures, there is no guarantee of avoiding Down syndrome. For parents facing this diagnosis, support and preparation are key.
1. Building a Support Network
Families can connect with local and international Down syndrome organizations for resources, support, and education.
2. Embracing Medical Care and Therapy
Children with Down syndrome benefit greatly from early medical care, speech therapy, physical therapy, and educational programs tailored to their needs.
3. Celebrating Individual Potential
Many individuals with Down syndrome lead fulfilling lives, contributing to their communities in meaningful ways. Parents should focus on nurturing their child’s unique abilities and potential.
Conclusion
Avoiding Down syndrome requires a proactive approach that includes genetic testing, advanced reproductive technologies, and informed decision-making. While risk factors such as maternal age can’t always be controlled, tools like PGT, prenatal screening, and gender selection empower parents to plan for healthier pregnancies. In Dubai and around the world, advancements in medical technology make it possible to detect and manage genetic conditions like Down syndrome early. By consulting with genetic counselors and leveraging cutting-edge fertility techniques, expecting parents can take meaningful steps to minimize risks while embracing the joys of parenthood. For families navigating these choices, knowledge and preparation are invaluable. Whether through early testing, IVF, or other medical interventions, taking proactive steps helps ensure the best possible outcome for parents and their children.
تحديد جنس المولود
0 notes
Text
Gender Prediction Myths vs. Facts: What Expecting Parents Should Know
Expecting a child is a time filled with joy, anticipation, and plenty of curiosity, especially regarding the baby’s gender. Over the years, various traditions and tales have emerged, each claiming to predict whether parents can expect a baby boy or girl. These myths, often passed down through generations, add a fun, lighthearted element to the pregnancy journey. However, for many parents, knowing the truth behind these claims is essential to prevent potential disappointment or misconceptions. While gender prediction myths may add excitement, they are rarely backed by science. As modern medicine advances, expecting parents now have access to safe and accurate gender detection options that eliminate guesswork. This blog will explore some of the most common gender prediction myths debunked by the experts of a baby gender blood test clinic in the UK and will reveal the scientific truth behind each.
Understanding Gender Prediction Myths:
Pregnancy has inspired various gender prediction myths, often passed down through generations. These myths might be fun to consider but are scientifically unproven.
1. Myth: The Shape And Position Of The Baby Bump Can Reveal Gender-
One of the most popular myths claims that a high bump means a girl, while a low bump means a boy. This belief persists worldwide, suggesting that the baby’s position in the womb determines its gender. However, no evidence links bump shape or height to the baby’s sex.
2. Myth: Cravings For Sweet Or Salty Foods Predict Gender-
Another well-known gender prediction myth relates to food cravings. According to this myth, craving sweets means a girl, while craving for salty foods indicates a boy. In reality, pregnancy cravings are triggered by hormonal changes and do not indicate a baby’s sex.
3. Myth: The Heart Rate Method For Gender Prediction-
Some people believe that a baby’s heart rate can determine its gender, with rates above 140 bpm supposedly indicating a girl and rates below indicating a boy. While it’s true that fetal heart rates fluctuate, there is no scientific correlation between heart rate and gender.
The Facts: Scientific Methods for Determining Gender:
With advancements in prenatal care, expecting parents can now access accurate and safe methods for gender determination. These scientific methods provide reliable results, unlike traditional myths.
1. Ultrasound Scans-
Ultrasound scans, commonly performed around the 20-week mark, are one of the most reliable ways to determine a baby’s gender. Skilled technicians can often detect the baby’s sex through high-resolution imagery.
2. Non-Invasive Prenatal Testing (NIPT)-
NIPT is a highly accurate method of detecting a baby’s gender as early as 10 weeks into pregnancy. This blood test examines the fetal DNA present in the mother’s bloodstream, allowing for a safe and early gender determination.
3. Chorionic Villus Sampling (CVS) And Amniocentesis-
For parents with specific genetic concerns, procedures like CVS and amniocentesis can confirm the baby’s gender.
Why It’s Important To Rely On Facts-
While myths may bring joy and excitement, it’s important to rely on scientifically backed methods for an accurate determination of your baby’s gender. Scientific tests provide clarity and prevent unnecessary stress or disappointment, helping parents prepare for the journey ahead.
To wrap up, gender prediction myths have been part of pregnancy folklore for generations, offering lighthearted fun and adding to the excitement of expecting a child. However, they lack scientific backing, and expecting parents should approach them with caution. Thankfully, reliable, evidence-based methods such as ultrasounds and NIPT offer safe and accurate gender determination options. For parents curious to know their baby’s gender early, visit the BlueorPink clinic in the UK for a trusted early gender detection test. The clinic provides a professional and compassionate environment, ensuring a comfortable experience for expecting parents. Get clarity and start preparing for your new arrival with confidence!
Also Read: Understanding The Emotional Impact of Early Gender Blood Tests
#early gender dna test uk#early gender detection test uk#6 weeks gender blood test uk#early gender blood test uk#baby gender blood test uk#early gender detection test#early gender detection test london#6 weeks gender blood test london
0 notes
Text
Innovations Transforming the Prenatal Diagnostics Market Landscape
Prenatal Diagnostics refers to a range of medical tests and procedures conducted during pregnancy to assess the health of the fetus. The primary goal is to detect any genetic abnormalities, chromosomal disorders, or other potential health issues early on, enabling parents and healthcare providers to make informed decisions about care. These diagnostics are essential for ensuring the well-being of both the mother and the baby, offering insights into conditions like Down syndrome, cystic fibrosis, neural tube defects, and other congenital anomalies.
The Prenatal Diagnostics Market Size was projected to reach 16.02 billion USD in 2022, according to MRFR analysis. By 2032, the prenatal diagnostics market is projected to have grown from 16.79 billion USD in 2023 to 25.7 billion USD. Over the course of the forecast period (2024–2032), the prenatal diagnostics market is anticipated to develop at a CAGR of approximately 4.84%.
Prenatal diagnostics can be broadly classified into screening tests and diagnostic tests. Screening tests, such as blood tests and ultrasounds, are non-invasive and provide an assessment of the risk of certain conditions. In contrast, diagnostic tests like amniocentesis and chorionic villus sampling (CVS) are more invasive but provide definitive information about genetic abnormalities.
Size and Share of the Prenatal Diagnostics Market
The Prenatal Diagnostics market has experienced significant growth over the past decade and is projected to continue expanding. As of recent reports, the global market size was estimated at over USD 5 billion in 2023, with an anticipated compound annual growth rate (CAGR) of approximately 10% from 2024 to 2030. The increasing demand for non-invasive prenatal testing (NIPT), advancements in genetic screening technologies, and rising awareness about prenatal health are major factors driving this growth.
North America holds the largest market share due to advanced healthcare infrastructure, high adoption rates of prenatal testing, and robust healthcare policies. Europe follows closely, with increasing government support for early genetic testing and a growing aging maternal population. The Asia-Pacific region is expected to witness the fastest growth due to rising healthcare investments, improving diagnostic capabilities, and an increasing number of pregnancies in countries like India and China.
Prenatal Diagnostics Analysis
The Prenatal Diagnostics market analysis reveals a dynamic landscape characterized by rapid technological advancements, increasing consumer awareness, and a focus on non-invasive testing methods. Non-invasive prenatal testing (NIPT) has emerged as a game-changer, offering a safer, more accessible option for detecting chromosomal abnormalities. The test analyzes cell-free fetal DNA circulating in the maternal blood to identify potential genetic conditions, making it less risky than invasive methods like amniocentesis.
Technological innovations, such as the development of next-generation sequencing (NGS) and polymerase chain reaction (PCR) techniques, have enhanced the accuracy and efficiency of prenatal tests. The integration of artificial intelligence (AI) and machine learning in data analysis is further improving the reliability of diagnostic results, reducing false positives, and enabling personalized risk assessments.
Furthermore, regulatory approvals and increasing investment in research and development (R&D) are driving market growth. Companies are investing in developing cost-effective, efficient, and less invasive diagnostic solutions, catering to the rising demand from expecting parents.
Prenatal Diagnostics Trends
Several key trends are shaping the Prenatal Diagnostics market:
Rising Demand for Non-Invasive Testing: With the increasing awareness of the risks associated with invasive procedures, there is a growing preference for non-invasive prenatal testing (NIPT), which poses no risk to the fetus and offers early detection of chromosomal abnormalities.
Technological Advancements: The adoption of advanced genetic sequencing technologies, including next-generation sequencing (NGS) and microarray analysis, is enhancing the accuracy and scope of prenatal diagnostics. These technologies allow for more detailed genetic profiling, improving diagnostic outcomes.
Increased Awareness and Early Detection: Public health initiatives and educational campaigns are raising awareness about the importance of prenatal care, leading to higher adoption rates of prenatal diagnostic tests. Early detection enables timely interventions, improving maternal and fetal outcomes.
Integration of AI and Machine Learning: The application of AI in prenatal diagnostics is streamlining the interpretation of complex genetic data, reducing human error, and enabling more precise risk stratification. AI algorithms are improving diagnostic accuracy, particularly in complex cases with ambiguous results.
Expansion in Emerging Markets: The growing healthcare infrastructure in emerging markets, coupled with rising disposable income and increased awareness about prenatal care, is driving the adoption of prenatal diagnostic tests in these regions.
Reasons to Buy Prenatal Diagnostics Market Reports
Comprehensive Market Insights: Obtain a detailed analysis of the Prenatal Diagnostics market, including size, share, growth potential, and competitive landscape, to make informed business decisions.
Up-to-Date Market Trends: Stay updated on the latest technological advancements, emerging trends, and regulatory developments shaping the prenatal diagnostics industry.
Strategic Planning: Gain insights into key growth drivers, challenges, and opportunities in the market to develop effective business strategies and investment plans.
Competitive Analysis: Understand the competitive landscape, including key players, their market strategies, and innovations, to identify potential partnerships or areas for investment.
Market Forecast and Predictions: Access accurate market forecasts to anticipate future developments and adjust business strategies accordingly.
Recent Developments in Prenatal Diagnostics
Advancement in NIPT Technology: Companies have been developing advanced NIPT solutions that offer higher sensitivity and specificity, reducing the need for follow-up invasive testing.
Regulatory Approvals: Recent approvals by regulatory bodies like the FDA have expanded the use of certain prenatal tests, making them more widely available and reliable for detecting a broader range of genetic disorders.
AI Integration: The integration of AI in prenatal diagnostics is enhancing data analysis capabilities, providing more accurate and timely results to healthcare providers and patients.
Expansion into Emerging Markets: Major players are increasingly investing in emerging markets to tap into the growing demand for prenatal diagnostics, driven by rising healthcare awareness and improved medical infrastructure.
Collaborations and Partnerships: Key industry players are forming strategic collaborations with biotech companies and research institutions to advance prenatal diagnostic technologies and expand their product offerings.
The Prenatal Diagnostics market is poised for substantial growth as innovations continue to enhance the accuracy, accessibility, and safety of prenatal testing, ultimately improving maternal and fetal health outcomes.
rElated reports:
Dental Contouring Market
Dermatology Drug Market
Facial Implant Market
Feeding Tube Market
Healthcare Informatics Market
Top of Form
Bottom of Form
0 notes
Text
Understanding Preimplantation Genetic Testing Market: Trends and Insights
The global preimplantation genetic testing (PGT) market was estimated to be valued at USD 802.2 million in 2023, with projections indicating a compound annual growth rate (CAGR) of 10.3% from 2024 to 2030. This growth is largely driven by the increasing prevalence of single-gene, mitochondrial, and other genetic disorders, which is anticipated to elevate the demand for preimplantation diagnostic and screening processes in the upcoming years. According to the Florida Department of Health, around one in every 33 babies born in the U.S. is affected by a congenital disability, resulting in nearly 120,000 affected infants annually. As new testing options are introduced, demand for these services is expected to rise. For instance, in July 2023, Thermo Fisher Scientific Inc. launched two next-generation sequencing (NGS)-based tests specifically designed for preimplantation genetic testing for aneuploidy (PGT-A).
The integration of aneuploidy screening in preimplantation genetic diagnosis (PGD) has significantly enhanced in vitro fertilization (IVF) procedures. By utilizing aneuploidy testing in IVF centers, healthcare providers can identify embryos with chromosomal abnormalities, which leads to improved pregnancy success rates. Preimplantation genetic testing for aneuploidy (PGT-A) assesses embryos for chromosomal integrity, ensuring they possess the correct number of chromosomes. The benefits of PGT-A—such as higher chances of pregnancy, lower miscarriage rates, and fewer IVF cycles required to achieve a successful pregnancy—are expected to further stimulate the adoption of these tests in the forecast period.
Gather more insights about the market drivers, restrains and growth of the Preimplantation Genetic Testing Market
Industry Dynamics
The preimplantation genetic testing market has experienced considerable innovation, marked by advancements like PGT-A and PGT-M. These developments enhance diagnostic accuracy, mitigate risks, and improve pregnancy success rates, which collectively drive market expansion and deliver better outcomes for individuals dealing with genetic and fertility challenges.
The market landscape is characterized by key players who engage in moderate levels of product launches and merger and acquisition (M&A) activities. Companies are increasingly consolidating their resources to harness advanced technologies, broaden their market presence, and enhance their service offerings. This trend is instrumental in fostering growth and innovation within the sector, ultimately improving outcomes for patients seeking genetic and fertility solutions.
Regulatory frameworks play a significant role in shaping the preimplantation genetic testing market, ensuring that safety, efficacy, and ethical standards are maintained. Stringent regulations govern the development and implementation of testing procedures, thereby building trust among patients and healthcare practitioners. However, the complexity of these regulations can also present challenges for market entry and innovation, potentially affecting the speed of technological advancements.
In terms of alternatives, the preimplantation genetic testing market faces competition from traditional prenatal diagnostic methods, such as amniocentesis and chorionic villus sampling (CVS). Unlike PGT, these conventional methods assess genetic disorders only after pregnancy has been established, which can lead to difficult choices if abnormalities are detected. While these alternatives provide diagnostic options, they do not offer the early intervention advantages that PGT presents.
Order a free sample PDF of the Preimplantation Genetic Testing Market Intelligence Study, published by Grand View Research.
#Preimplantation Genetic Testing Market#Preimplantation Genetic Testing Market Report#Preimplantation Genetic Testing Market Analysis#Preimplantation Genetic Testing Industry
0 notes
Text
NIPS Test by RML Pathology: Why It's Important for Expecting Parents
Pregnancy is an exciting time, filled with anticipation and hope. Along with all the joy, expecting parents naturally wonder about their baby’s health and development. The Non-Invasive Prenatal Screening (NIPS) Test, offered by RML Pathology, is one of the most advanced tests to help parents gain important insights into their baby’s health, without any risk to the mother or child. Here, we’ll break down what the NIPS Test is, why it’s important, and how it can bring peace of mind to you and your family.
What Is the NIPS Test?
The Non-Invasive Prenatal Screening (NIPS) Test is a simple blood test designed to detect certain chromosomal conditions in a developing baby. Unlike more invasive procedures like amniocentesis, which carry some risks, the NIPS Test poses no risk to the mother or baby. Instead, it uses a sample of the mother’s blood to screen for potential genetic abnormalities, such as Down syndrome, trisomy 13, and trisomy 18.
Why the NIPS Test Is Important
Early Awareness for Informed Decisions The NIPS Test can detect chromosomal abnormalities as early as 10 weeks into pregnancy. Early screening enables parents to make informed decisions about the pregnancy, whether it’s preparing emotionally or understanding any special needs that the child might have.
Peace of Mind for Expecting Parents For most parents, the results of the NIPS Test provide a sigh of relief, as the majority of screenings come back normal. But for those who do get a positive result, knowing early allows them to seek additional guidance and plan for the future with clarity.
Non-Invasive and Safe Traditional tests for chromosomal abnormalities, such as amniocentesis and chorionic villus sampling (CVS), are more invasive and carry a small risk of miscarriage. The NIPS Test, however, simply requires a blood sample from the mother, making it 100% safe for both mother and baby.
Accurate and Reliable Results The NIPS Test has a high level of accuracy in detecting common chromosomal abnormalities, offering expecting parents confidence in the results. With a low rate of false positives, it allows for more reliable screening that doesn’t add unnecessary stress during an already delicate time.
Convenience and Accessibility At RML Pathology, we understand the need for convenient, accessible healthcare. We offer home sample collection for NIPS, allowing you to have the test done from the comfort of your home, without the need to visit a clinic or lab.
What to Expect During the NIPS Test
The NIPS Test is a quick, straightforward process. After scheduling your appointment, a qualified technician will take a blood sample, either at an RML Pathology center or in the comfort of your own home. This sample is then analyzed in our lab, and the results are shared with you and your healthcare provider within a short period.
Choosing RML Pathology for Your NIPS Test
At RML Pathology, we prioritize accuracy, quality, and compassionate care for all our patients. With a reputation as one of the most trusted pathology labs in Lucknow, we bring you the latest in medical technology and expertise to ensure that your prenatal testing is handled with the utmost care.
Why You Should Consider the NIPS Test
The journey of pregnancy is full of surprises, and while many of these are exciting, the health of your child shouldn’t be one of them. The NIPS Test offers a safe, reliable way to learn more about your baby’s genetic health early on, empowering you to prepare and plan with peace of mind. At RML Pathology, we’re here to support you every step of the way, offering accurate testing, compassionate care, and convenient services to make this important test as smooth as possible for you.
Contact us today to learn more or to schedule your NIPS Test.
#RMLPathology#NIPSTest#PrenatalScreening#EarlyDetection#ExpectingParents#PrenatalCare#SafeTesting#PeaceOfMind#GeneticScreening#PathologyTest#PregnancyCare#LucknowHealth#HealthMatters
1 note
·
View note
Text
How NIPT Works in IVF: Key Considerations for Fertility Treatments
As with any pregnancy, IVF pregnancies come with their own set of unique challenges, particularly in the area of genetic screening. One such advanced tool that has gained prominence in recent years is Non-Invasive Prenatal Testing (NIPT). This test provides critical genetic insights, offering parents the opportunity to detect potential chromosomal abnormalities early on in pregnancy. For couples in London who have conceived through IVF, understanding how NIPT works and its specific role in fertility treatments is crucial. This blog will explore how the NIPT test in the UK functions, its importance for IVF pregnancies, and the key considerations to keep in mind before opting for this test.
Why is NIPT Important for IVF Pregnancies?
For IVF pregnancies, genetic testing becomes even more critical. IVF procedures may involve older eggs, sperm from donors, or pre-existing genetic conditions in either parent. NIPT can provide vital information to detect any chromosomal abnormalities early on. As IVF pregnancies often face unique risks, understanding these risks through NIPT is a reassuring step. This test reduces the need for invasive procedures like amniocentesis, lowering the potential for complications during pregnancy.
NIPT in IVF with Donor Eggs or Sperm
One of the key considerations for IVF using donor eggs or sperm is the genetic material passed to the fetus. NIPT becomes essential in this scenario, as it screens for genetic abnormalities in pregnancies where the egg or sperm is from a donor. Many parents prefer this non-invasive approach to gain confidence in the pregnancy’s health, ensuring any chromosomal issues are detected as early as possible. Early detection of genetic conditions allows families to plan further care and make informed decisions.
The Role of NIPT in Multiple Pregnancies
IVF can often lead to multiple pregnancies, such as twins or triplets. In such cases, the NIPT test for pregnancy may face additional challenges, as it can be harder to distinguish between the genetic material of multiple fetuses. Despite these challenges, advances in NIPT technology have improved its accuracy, making it a useful tool in IVF-related multiple pregnancies. Consulting with a healthcare professional is essential to assess how effective NIPT will be in such cases.
Key Considerations Before Opting for NIPT in IVF
Before undergoing the NIPT gender test during an IVF pregnancy, there are several considerations to keep in mind. First, while NIPT is highly accurate for detecting chromosomal abnormalities, it is still a screening test, not a diagnostic one. Positive results may require further testing, like chorionic villus sampling (CVS) or amniocentesis, for confirmation. Second, timing is important. Most doctors recommend NIPT between weeks 10 and 14 for accurate results. Lastly, it’s important to discuss with your fertility specialist whether NIPT is the best option for your IVF pregnancy, based on your specific medical history.
Final Thoughts
NIPT has become a valuable tool in managing IVF pregnancies, offering early and non-invasive insights into the genetic health of the fetus. For those undergoing fertility treatments, NIPT provides an additional layer of reassurance, allowing families to prepare for potential challenges in the future. For couples in the UK, especially London, seeking an accurate NIPT test, consider reaching out to Concepto Diagnostics. Our advanced prenatal testing services provide reliable results, offering you peace of mind during your pregnancy journey. Contact us today for more information on how NIPT can benefit your IVF pregnancy. Also Read: Understanding the Statistics Behind NIPT (Non-Invasive Prenatal Testing)
0 notes
Text
Make the Horoscope of your Child by the NT Scan
A good radiologist or a foetal medicine specialist can be an expert horoscope maker most of time better than an astrologer because he or she has a better proved scientific approach.
HOW it is done you may wonder?
NT scan
NT scan is the key for him or her to make the horoscope. NT means Nuchael Translucency. It is the thickness of fluid behind the neck in the subcutaneous plane. NT scan is done between 11 weeks and 13 + 6 weeks (not 10 weeks 6 days or at 14 weeks) when the CRI- (total length from crown to rump) is between 45mm and 84mm.
The astrologer needs the correct time of birth and the child’s gender. Here the Doctor needs 5 things to make the horoscope chart.
The CRL
NT measurement
Nasal bone present or absent — all these obtained from scanning the fetus
From the maternal blood, he or she collects the levels of PAPP-A and
Free Beta HCG
He or she feeds all these to a computer which is loaded with special software which gives the result as follows
(a)Low risk (b) Intermediate risk (c) High risk
If the result is low risk, we will give a pass mark and allow the pregnancy to continue. No need to worry. This baby will have a more or less a normal life and will live up to death like any of us with all the pangs and happiness of life.
If the result is intermediate risk, we will give one more chance to the pregnancy by advising NIPT – a blood test for mother. If NIPT is negative, they are like the group mentioned above but if it is positive they fall into high risk category.
The high risk category— It is in this group, unfortunately the horoscope predictions will be bad for these children.
What to do with the high risk group?
To draw a “Thalakury” and predict the future instead of “Star Positions” we make it with four main factors.
Adenini
Quaninei
Cystinom and
Thyminym which the scientist call nucleotides
For more accurate reading of the Grahanila position we add three components of the nucleotides
(a) Phosphate group (b) A sugar molecule and (c) A nitrogen base
How is this data collected for the horoscope?
We do CVS (chorionic villus Sampling) before 14 weeks of pregnancy or amniocentesis after 16 weeks of pregnancy. These samples contain fetal cells. We culture it outside and multiply the cells. Then we analyse the chromosome and DNA by which we get all the data to draw the Grahanila.
Predictions
Will the parent get a full term baby or will the pregnancy end up in intra uterine fetal death?
If the DNA test comes as Edwards syndrome — trisomy 18 (Extra chromosome 18); PATAVU Syndrome (Trisomy 13); TURNER Syndrome (Monosomy X) ; TRIPLOIDY Hydatid mole ; Osteogenesis imperfect type Il, severe case of congenital diaphragmatic hernia; SMITH LEMLI — OPITS Syndrome
In the above conditions one can predict that most probably the pregnancy will end up in IUD.
By scanning you can decide whether it is a male or female child (We do not reveal this to the patient, as this is against Indian law)
If it is a male child will it have IUD?
X linked recessive disorders (DUCHENNE MUSCULAR DYSTOPHY; Haemophilia A and B ; X linked Hydrocephalus ; X linked severe combined immino deficiency ( SCID); X linked ICHTHYOSIS (severe form of a skin disease), X linked lympho proliferative syndrome ; Menkes disease; X linked MYOTUBULAR MYOPATHY; HUNTER SYNDROME; ORNITHINE TRANSCARBAMYLASE Deficiency – All usually will lead to IUD.
If it is a female fetus will it live up to term?
TURNER SYNDROME (MONOSOMY X); REIT Syndrome; Congenital adrenal hyperplasia; LEIGH syndrome; GOLTS Syndrome, severe form of cystic fibrosis etc. may end up in IUD
In the horoscope we can predict this “BOY” may not reach adulthood — like the story of MARKENDAYAN in Hindu mythology or we can predict the “GIRL” may not reach adulthood.
Also like “SARPADOSHAM” we can indicate this female child will potentially pass the disease to their offsprings.
0 notes
Text
Harmony Test Price: Understanding the Cost of Prenatal Screening
Navigating pregnancy can be an exciting yet overwhelming experience for expecting parents. Among the many decisions to make is whether to undergo prenatal screening tests, like the Harmony Test. This non-invasive prenatal test (NIPT) provides essential information about your baby’s genetic health. At Clinique ovo, we offer comprehensive prenatal services, including the Harmony Test, and aim to help parents understand the costs involved.
What is the Harmony Test?
The Harmony Test is a blood test designed to assess the risk of certain genetic conditions in a developing fetus, including Down syndrome (trisomy 21), trisomy 18, and trisomy 13. This test analyzes fragments of fetal DNA circulating in a pregnant person's bloodstream, providing a highly accurate risk assessment for these chromosomal abnormalities.
Why Consider the Harmony Test?
Expecting parents may opt for the Harmony Test for various reasons:
Non-Invasive: Unlike traditional invasive procedures, such as amniocentesis or chorionic villus sampling (CVS), the Harmony Test poses no risk of miscarriage since it only requires a simple blood draw.
Early Detection: The test can be performed as early as the 10th week of pregnancy, allowing parents to gain insight into their baby’s genetic health early on.
High Accuracy: The Harmony Test boasts a high sensitivity and specificity rate, making it one of the most reliable prenatal screening tests available today.
Peace of Mind: For many parents, the Harmony Test provides reassurance by reducing uncertainty regarding the health of their baby.
Understanding the Harmony Test Price
When considering the Harmony Test, understanding the associated costs is essential for making informed decisions. Here’s a breakdown of what you can expect regarding the Harmony Test price:
Test Costs: The price of the Harmony Test can vary based on several factors, including the clinic, geographic location, and specific services included. On average, you can expect to pay between $400 and $1,000 for the test. At Clinique ovo, we strive to offer competitive pricing to make prenatal screening accessible to all families.
Insurance Coverage: Many insurance plans may cover some or all of the cost of the Harmony Test, especially if there are medical indications or risk factors. It’s important to check with your insurance provider to understand your coverage and any out-of-pocket expenses you may incur.
Additional Fees: Consider any additional costs that may arise, such as consultation fees, follow-up appointments, or additional tests that may be recommended based on the Harmony Test results.
Financial Assistance: If the cost is a concern, ask your healthcare provider about any financial assistance programs or payment plans available to help ease the financial burden.
Why Choose Clinique ovo for the Harmony Test?
At Clinique ovo, we are dedicated to providing exceptional prenatal care and services, including the Harmony Test. Here’s what sets us apart:
Expert Care: Our team of experienced professionals is committed to ensuring that you receive comprehensive support throughout the testing process, from consultation to results.
Comfortable Environment: We strive to create a welcoming and supportive atmosphere for expecting parents, making your experience as stress-free as possible.
Advanced Technology: We utilize state-of-the-art technology to provide accurate and reliable results for our prenatal screening tests.
Conclusion
The Harmony Test is an invaluable tool for expecting parents who want to gain insights into their baby’s genetic health early in pregnancy. Understanding the Harmony Test tarif and the factors influencing it can help you make informed decisions. At Clinique ovo, we are here to support you throughout your pregnancy journey, providing high-quality prenatal services tailored to your needs. To learn more about the Harmony Test and our services, visit us.
0 notes
Text
How cfDNA testing has changed prenatal care
New Post has been published on https://thedigitalinsider.com/how-cfdna-testing-has-changed-prenatal-care/
How cfDNA testing has changed prenatal care
The much-touted arrival of “precision medicine” promises tailored technologies that help individuals and may also reduce health care costs. New research shows how pregnancy screening can meet both of these objectives, but the findings also highlight how precision medicine must be matched well with patients to save money.
The study involves cfDNA screenings, a type of blood test that can reveal conditions based on chromosomal variation, such as Down Syndrome. For many pregnant women, though not all, cfDNA screenings can be an alternative to amniocentesis or chorionic villus sampling (CVS) — invasive procedures that come with a risk of miscarriage.
In examining how widely cfDNA tests should be used, the study reached a striking conclusion.
“What we find is the highest value for the cfDNA testing comes from people who are high risk, but not extraordinarily high risk,” says Amy Finkelstein, an MIT economist and co-author of a newly published paper detailing the study.
The paper, “Targeting Precision Medicine: Evidence from Prenatal Screening,” appears in the Journal of Political Economy. The co-authors are Peter Conner, an associate professor and senior consultant at Karolinska University Hospital in Sweden; Liran Einav, a professor of economics at Stanford University; Finkelstein, the John and Jennie S. MacDonald Professor of Economics at MIT; and Petra Persson, an assistant professor of economics at Stanford University.
“There is a lot of hope attached to precision medicine,” Persson says. “We can do a lot of new things and tailor health care treatments to patients, which holds a lot of promise. In this paper, we highlight that while this is all true, there are also significant costs in the personalization of medicine. As a society, we may want to examine how to use these technologies while keeping an eye on health care costs.”
Measuring the benefit to “middle-risk” patients
To conduct the study, the research team looked at the introduction of cfDNA screening in Sweden, during the period from 2011 to 2019, with data covering over 230,000 pregnancies. As it happens, there were also regional discrepancies in the extent to which cfDNA screenings were covered by Swedish health care, for patients not already committed to having invasive testing. Some regions covered cfDNA testing quite widely, for all patients with a “moderate” assessed risk or higher; other regions, by contrast, restricted coverage to a subset of patients within that group with elevated risk profiles. This provided variation the researchers could use when conducting their analysis.
With the most generous coverage of cfDNA testing, the procedure was used by 86 percent of patients; with more targeted coverage, that figure dropped to about 33 percent. In both cases, the amount of invasive testing, including amniocentesis, dropped significantly, to about 5 percent. (The cfDNA screenings are very informative, but not fully conclusive, which invasive testing is, so some pregnant women will opt-for a follow-up procedure.)
Both approaches, then, yielded similar reductions in the rate of invasive testing. But due to the costs of cfDNA tests, the economic implications are quite different. Introducing wide coverage of cfDNA tests would raise overall medical costs by about $250 per pregnancy, the study estimates. In contrast, introducing cfDNA with more targeted coverage yields a reduction of about $89 per patient.
Ultimately, the larger dynamics are clear. Pregnant women who have the highest risk of bearing children with chromosome-based conditions are likely to still opt for an invasive test like amniocentesis. Those with virtually no risk may not even have cfDNA tests done. For a group in between, cfDNA tests have a substantial medical value, relieving them of the need for an invasive test. And narrowing the group of patients getting cfDNA tests lowers the overall cost.
“People who are very high-risk are often going to use the invasive test, which is definitive, regardless of whether they have a cfDNA screen or not,” Finkelstein says. “But for middle-risk people, covering cfDNA produces a big increase in cfDNA testing, and that produces a big decline in the rates of the riskier, and more expensive, invasive test.”
How precise?
In turn, the study’s findings raise a larger point. Precision medicine, in almost any form, will add expenses to medical care. Therefore developing some precision about who receives it is significant.
“The allure of precision medicine is targeting people who need it, so we don’t do expensive and potentially unpleasant tests and treatments of people who don’t need them,” Finkelstein says. “Which sounds great, but it kicks the can down the road. You still need to figure out who is a candidate for which kind of precision medicine.”
Therefore, in medicine, instead of just throwing technology at the problem, we may want to aim carefully, where evidence warrants it. Overall, that means good precision medicine builds on good policy analysis, not just good technology.
“Sometimes when we think medical technology has an impact, we simply ask if the technology raises or lowers health care costs, or if it makes patients healthier,” Persson observes. “An important insight from our work, I think, is that the answers are not just about the technology. It’s about the pairing of technology and policy because policy is going to influence the impact of technology on health care and patient outcomes. We see this clearly in our study.”
In this case, finding comparable patient outcomes with narrower cfDNA screenings suggests one way of targeting diagnostic procedures. And across many possible medical situations, finding the subset of people for whom a technology is most likely to yield new and actionable information seems a promising objective.
“The benefit is not just an innate feature of the testing,” Finkelstein says. “With diagnostic technologies, the value of information is greatest when you’re neither obviously appropriate or inappropriate for the next treatment. It’s really the non-monotone value of information that’s interesting.”
The study was supported, in part, by the U.S. National Science Foundation.
#000#250#ADD#Analysis#author#bearing#blood#Children#data#dynamics#economic#Economics#economy#eye#form#Foundation#Health#Health care#how#how to#How to Use#impact#InSight#it#medical#Medicine#miscarriage#mit#money#One
0 notes
Text
Amniocentesis Test Sharjah | Mothers and Fetuses Group
A specific prenatal test called an amniocentesis test in Sharjah can find genetic anomalies in a growing fetus. We provide this test to pregnant moms who are at a higher risk for chromosomal or genetic problems at Mother and Fetuses Medical Center Hospital. A tiny needle is placed into the mother's belly to access the amniotic sac around the fetus and collect a small sample of amniotic fluid. After that, the material is examined in a lab to look for any anomalies.
Amniocentesis carries a modest risk of miscarriage despite being a very accurate test. To assist you in making an informed choice, our team of knowledgeable physicians and genetic counselors will go over the procedure's advantages and disadvantages with you. We recommend setting up a meeting with our staff at Mother and Fetuses Medical Center Hospital if you are thinking about having an amniocentesis. In order to guarantee the greatest outcome for you and your child, we are devoted to provide individual and sensitive treatment.
0 notes
Text
How cfDNA testing has changed prenatal care
New Post has been published on https://sunalei.org/news/how-cfdna-testing-has-changed-prenatal-care/
How cfDNA testing has changed prenatal care
The much-touted arrival of “precision medicine” promises tailored technologies that help individuals and may also reduce health care costs. New research shows how pregnancy screening can meet both of these objectives, but the findings also highlight how precision medicine must be matched well with patients to save money.
The study involves cfDNA screenings, a type of blood test that can reveal conditions based on chromosomal variation, such as Down Syndrome. For many pregnant women, though not all, cfDNA screenings can be an alternative to amniocentesis or chorionic villus sampling (CVS) — invasive procedures that come with a risk of miscarriage.
In examining how widely cfDNA tests should be used, the study reached a striking conclusion.
“What we find is the highest value for the cfDNA testing comes from people who are high risk, but not extraordinarily high risk,” says Amy Finkelstein, an MIT economist and co-author of a newly published paper detailing the study.
The paper, “Targeting Precision Medicine: Evidence from Prenatal Screening,” appears in the Journal of Political Economy. The co-authors are Peter Conner, an associate professor and senior consultant at Karolinska University Hospital in Sweden; Liran Einav, a professor of economics at Stanford University; Finkelstein, the John and Jennie S. MacDonald Professor of Economics at MIT; and Petra Persson, an assistant professor of economics at Stanford University.
“There is a lot of hope attached to precision medicine,” Persson says. “We can do a lot of new things and tailor health care treatments to patients, which holds a lot of promise. In this paper, we highlight that while this is all true, there are also significant costs in the personalization of medicine. As a society, we may want to examine how to use these technologies while keeping an eye on health care costs.”
Measuring the benefit to “middle-risk” patients
To conduct the study, the research team looked at the introduction of cfDNA screening in Sweden, during the period from 2011 to 2019, with data covering over 230,000 pregnancies. As it happens, there were also regional discrepancies in the extent to which cfDNA screenings were covered by Swedish health care, for patients not already committed to having invasive testing. Some regions covered cfDNA testing quite widely, for all patients with a “moderate” assessed risk or higher; other regions, by contrast, restricted coverage to a subset of patients within that group with elevated risk profiles. This provided variation the researchers could use when conducting their analysis.
With the most generous coverage of cfDNA testing, the procedure was used by 86 percent of patients; with more targeted coverage, that figure dropped to about 33 percent. In both cases, the amount of invasive testing, including amniocentesis, dropped significantly, to about 5 percent. (The cfDNA screenings are very informative, but not fully conclusive, which invasive testing is, so some pregnant women will opt-for a follow-up procedure.)
Both approaches, then, yielded similar reductions in the rate of invasive testing. But due to the costs of cfDNA tests, the economic implications are quite different. Introducing wide coverage of cfDNA tests would raise overall medical costs by about $250 per pregnancy, the study estimates. In contrast, introducing cfDNA with more targeted coverage yields a reduction of about $89 per patient.
Ultimately, the larger dynamics are clear. Pregnant women who have the highest risk of bearing children with chromosome-based conditions are likely to still opt for an invasive test like amniocentesis. Those with virtually no risk may not even have cfDNA tests done. For a group in between, cfDNA tests have a substantial medical value, relieving them of the need for an invasive test. And narrowing the group of patients getting cfDNA tests lowers the overall cost.
“People who are very high-risk are often going to use the invasive test, which is definitive, regardless of whether they have a cfDNA screen or not,” Finkelstein says. “But for middle-risk people, covering cfDNA produces a big increase in cfDNA testing, and that produces a big decline in the rates of the riskier, and more expensive, invasive test.”
How precise?
In turn, the study’s findings raise a larger point. Precision medicine, in almost any form, will add expenses to medical care. Therefore developing some precision about who receives it is significant.
“The allure of precision medicine is targeting people who need it, so we don’t do expensive and potentially unpleasant tests and treatments of people who don’t need them,” Finkelstein says. “Which sounds great, but it kicks the can down the road. You still need to figure out who is a candidate for which kind of precision medicine.”
Therefore, in medicine, instead of just throwing technology at the problem, we may want to aim carefully, where evidence warrants it. Overall, that means good precision medicine builds on good policy analysis, not just good technology.
“Sometimes when we think medical technology has an impact, we simply ask if the technology raises or lowers health care costs, or if it makes patients healthier,” Persson observes. “An important insight from our work, I think, is that the answers are not just about the technology. It’s about the pairing of technology and policy because policy is going to influence the impact of technology on health care and patient outcomes. We see this clearly in our study.”
In this case, finding comparable patient outcomes with narrower cfDNA screenings suggests one way of targeting diagnostic procedures. And across many possible medical situations, finding the subset of people for whom a technology is most likely to yield new and actionable information seems a promising objective.
“The benefit is not just an innate feature of the testing,” Finkelstein says. “With diagnostic technologies, the value of information is greatest when you’re neither obviously appropriate or inappropriate for the next treatment. It’s really the non-monotone value of information that’s interesting.”
The study was supported, in part, by the U.S. National Science Foundation.
0 notes
Text
Understanding Common Genetic Disorders: Causes, Symptoms, and Treatments
Genetic abnormalities result from changes or irregularities in an organism’s genome. These abnormalities can stem from mutations in one gene or several genes, as well as variations in the number or composition of chromosomes. Certain genetic disorders are congenital, meaning they are present at birth, while others are acquired as a result of mutations in specific genes. Inherited genetic disorders, like cystic fibrosis, hemophilia, and sickle cell anemia, are passed down from parents. On the other hand, genetic disorders acquired during one’s lifetime are not inherited and can be caused by random mutations or exposure to various factors such as chemicals, environments, or radiation like cigarette smoke or UV rays. Cancer is a prime example of a disease that can be acquired in this manner.
In this blog, we can see some of the common genetic disorders, and its symptoms and treatments.
Down Syndrome
Down Syndrome is caused by an extra copy of chromosome 21 (trisomy 21). This extra genetic material affects development.
The main symptoms are characteristic facial features (flattened face, almond-shaped eyes), intellectual disability, developmental delays, and potential heart defects. There is no cure for Down syndrome, but early intervention, educational programs, and therapies (speech, occupational, physical) can help improve skills. Regular medical care is necessary to manage associated health issues.
Cystic Fibrosis
Caused by mutations in the CFTR gene, which affects the cells that produce mucus, sweat, and digestive juices. The secretions become thick and sticky, causing blockages.
Symptoms are persistent coughing, frequent lung infections, wheezing, difficulty breathing, poor growth, and fatty stools.
Treatments include chest physiotherapy, medications to thin mucus, antibiotics to prevent infections, pancreatic enzyme supplements, and a high-calorie diet. In severe cases, lung transplants may be considered.
Multifactorial Genetic Inheritance
This phenomenon is also referred to as polygenic inheritance. It arises due to a combination of environmental factors and gene mutations. Several disorders exemplify this type of inheritance, including: Heart disease, High blood pressure, Alzheimer’s disease, Obesity, Diabetes, Cancer, and Arthritis.
Sickle Cell Anemia
Caused by a mutation in the HBB gene, leading to the production of abnormal hemoglobin (hemoglobin S). This causes red blood cells to become rigid and sickle-shaped.
Symptoms are anemia, episodes of pain (crises), frequent infections, delayed growth, and vision problems. Treatments are pain management, blood transfusions, hydroxyurea (to reduce the frequency of pain crises), and bone marrow transplants in severe cases. Gene therapy is being researched as a potential cure.
Methods To Test Genetic Disorders
Genetic Counseling: Provides information and support to families at risk of genetic disorders. Helps understand inheritance patterns, testing options, and implications.
Prenatal Testing: Can identify certain genetic disorders before birth. Techniques include amniocentesis, chorionic villus sampling (CVS), and non-invasive prenatal testing (NIPT).
Newborn Screening: Identifies genetic disorders early in life, allowing for prompt treatment. Tests for conditions like PKU and cystic fibrosis are common.
Gene Therapy: Emerging treatment aimed at correcting defective genes. It’s still largely experimental but holds promise for conditions like cystic fibrosis and sickle cell anemia.
Understanding and managing genetic disorders involves a multi-faceted approach that includes medical intervention, supportive therapies, and ongoing research to develop new treatments. Early detection and personalized care are crucial in improving outcomes for individuals with genetic disorders.
0 notes
Text
Prenatal Genetic Testing: Which Tests Do You Need?
Prenatal genetic testing gives information about birth abnormalities. You can talk to the doctor about which test is right for you. Prenatal genetic testing is an optional test that is an entirely personal choice in case you want to check the health of the fetus.
Some families choose to do the testing due to various reasons including the irregular result of the genetic screening test, conceiving after the age of 35 years old, having an history of miscarriage, or and genetic issue in your family. If you are planning to conceive you can get a genetic testing in Siliguri for the better health of your baby.
There are two different kinds of prenatal genetic testing: screening test and other is diagnostic tests.
1.Prenatal screening tests
Prenatal screening tests diagnose if the fetus has any abnormality. The test doesn’t give results about the abnormality of the fetus. If the screening test is showing sign of abnormality in the fetus that doesn’t mean the fetus has a condition, it only shows that there are some risks of genetic disorders. Once you get the result from the screening test your doctors will tell you about the next steps in case of abnormal results.
In most cases, the doctors will recommend you for diagnostic testing. Diagnostic testing in contrast takes samples from you to get the result to answer if the fetus has inherited a genetic condition. This process is only allowed after you get abnormal results from the screening test.
Prenatal genetic screening testing is of many types:
Carrier screening
This sort of screening is done once in your lifetime and can tell you if you have if you are a carrier of a genetic risk. It takes blood from you are your partner to start with the test. This test can identify small changes in the genes that can potentially make the child born with the inherited disease. Once that happens your partner will be checked and in case he also has the same genetic risk then there are huge chances that the baby could have a more severe form of the disease.
Abnormalities due to chromosome number
Screening for abnormal chromosomes is done in case of problems when chromosomes aren’t inherited in pairs. In some cases, the natural fertilization process makes mistakes and causes the issue. There are many types of screening tests to determine the abnormal chromosome number which can cause genetic conditions.
Cell-free fetal DNA screening:The doctor checks for some common abnormal chromosome numbers in small bits of fetal DNA in your body.
Serum screening:this test takes your blood for the test and uses it to analyze protein levels to determine the abnormalities
Physical abnormalities
Screening is done to check the physical abnormalities of the fetus. In case there are missing or extra chromosomes, it can cause defects in the baby’s physical body.
The test is done in many ways:
Nuchal translucency
Use ultrasound to measure the thickness of the neck of the fetus and this gives clues to risk for abnormal chromosome number and abnormal fetal heart formation.
AFP screening (maternal serum screen): with your blood test the clues are given by measuring the AFP in the blood. If high then there are chances of physical problems in the abdomen, face, and spine..
Quad screen:Here four substances in your blood are measured to check chromosomal abnormalities and chances of neural tube defects..
Fetal anatomy scan: the ultrasound is done to check the physical structure of the baby. The ultrasound is done to check the physical structure of the baby.
2. Diagnostic test
After the screening test, there is a diagnostic test that confirms the genetic condition of the fetus. These tests are only possible after passing through a screening test which will tell you the possibility of a genetic condition. The common diagnostic tests are amniocentesis and chorionic villus sampling (CVS).
Amniocentesis: In this test, a needle is inserted through your skin into your uterus to get a sample of amniotic fluid from the amniotic sac.
CVS: In this test needle is inserted in your uterus to get a sample of cells from the placenta.
These samples were then sent for analysis. The diagnostic test performs several types of diagnostic tests to give the final result after they take the proper samples from you. This test can take 72 hours to a few weeks before the result gets out.
Congenital disorders are present at birth so they can be diagnosed before the baby even gets to be born. You can check for the DNA test in Siliguri. Some people choose to do the parental genetic test along with another test during their pregnancy. Whether you want to take the test or not depends on you.
Conclusion
Doing the prenatal genetic test is optional. Some people take this test when during the screening test they get some bad results. While other do the test to monitor the health of the fetus. In some cases, parents hear the worst news from doctors for genetic testing in Siliguri or other hospitals and they recommend thinking again if want to continue with the pregnancy.
0 notes
Text
Fetal Medicine Specialist in Siliguri: Comprehensive Guide to Maternal and Fetal Healthcare
Siliguri, a bustling city located at the foothills of the Himalayas, is not only known for its scenic beauty and commercial significance but is also rapidly emerging as a hub for advanced medical care in northeast India. Among the various medical specializations gaining prominence in the region, fetal medicine stands out for its importance in ensuring maternal and fetal well-being during pregnancy.
If you're seeking expert care during pregnancy, particularly when facing high-risk conditions, consulting a fetal medicine specialist in Siliguri can make a significant difference. This blog delves into the vital role of fetal medicine, the services provided by specialists, and why Siliguri is becoming a key destination for advanced maternal and fetal healthcare.
What is Fetal Medicine?
Fetal medicine, also known as perinatology or maternal-fetal medicine, is a branch of medicine that focuses on the health of the fetus and the mother during pregnancy. Fetal medicine specialists are obstetricians who undergo additional training to manage high-risk pregnancies, prenatal diagnosis, and fetal therapy. These specialists work to detect, monitor, and treat complications that may arise in the fetus or the mother, ensuring both receive the best possible care throughout pregnancy and during childbirth.
Fetal medicine is an interdisciplinary field, incorporating aspects of obstetrics, pediatrics, genetics, radiology, and surgery to offer comprehensive care. A fetal medicine specialist performs various diagnostic procedures and therapeutic interventions, often working in collaboration with other specialists like neonatologists, pediatric surgeons, and genetic counselors to provide holistic care.
The Role of a Fetal Medicine Specialist
Fetal medicine specialists manage a wide range of conditions that can affect both the mother and the fetus during pregnancy. Their primary role is to assess fetal health and detect any abnormalities early on to manage or treat them effectively. They are instrumental in improving outcomes in high-risk pregnancies and ensuring that both the mother and the fetus receive the appropriate medical attention.
Here are some key services offered by a fetal medicine specialist:
Prenatal Screening and Diagnosis
One of the most critical aspects of fetal medicine is prenatal screening and diagnosis. During pregnancy, fetal medicine specialists perform various tests to check for congenital anomalies, genetic disorders, and other potential complications. These tests include:
Ultrasound Scans: Detailed ultrasound imaging allows the specialist to examine the fetus's growth, development, and overall health. It can help detect structural abnormalities such as heart defects, spinal cord issues, or facial clefts.
Non-Invasive Prenatal Testing (NIPT): A blood test that analyzes fetal DNA circulating in the mother's blood to detect chromosomal abnormalities like Down syndrome, Edwards syndrome, and Patau syndrome.
Amniocentesis and Chorionic Villus Sampling (CVS): These are invasive procedures used to obtain samples of amniotic fluid or placental tissue to test for genetic conditions.
Management of High-Risk Pregnancies
Pregnancies that are considered high-risk due to conditions like maternal age, pre-existing medical issues (such as diabetes or hypertension), multiple pregnancies, or fetal abnormalities require close monitoring. A fetal medicine specialist can manage these pregnancies with advanced diagnostic tools and regular follow-ups to ensure the best possible outcome.
Fetal Therapy and Intervention
In certain cases, fetal therapy or intervention may be required to treat conditions affecting the fetus. Fetal medicine specialists are trained to perform procedures such as:
Fetoscopic Surgery: A minimally invasive procedure used to treat conditions like twin-to-twin transfusion syndrome (TTTS) or congenital diaphragmatic hernia.
Intrauterine Blood Transfusion: This is performed when a fetus has severe anemia, often due to Rh incompatibility between the mother and fetus.
Amnioreduction: A procedure to remove excess amniotic fluid in cases of polyhydramnios (too much amniotic fluid), which can reduce the risk of preterm labor and other complications.
Counseling and Support
Fetal medicine specialists provide counseling to expectant parents, helping them understand the nature of any diagnosed conditions, the risks involved, and the potential outcomes. They also offer guidance on treatment options and management plans, ensuring parents are well-informed and supported throughout their pregnancy journey.
Why Choose a Fetal Medicine Specialist in Siliguri?
Siliguri is witnessing a steady rise in advanced healthcare facilities, especially in fields like fetal medicine. Here's why you might consider seeking a fetal medicine specialist in Siliguri:
State-of-the-Art Medical Facilities
Several hospitals and clinics in Siliguri are equipped with the latest medical technologies for maternal and fetal care. These facilities offer cutting-edge diagnostic tools, such as 3D and 4D ultrasound imaging, fetal echocardiography, and genetic testing. The presence of neonatal intensive care units (NICUs) and advanced labor and delivery units ensures that both mother and baby receive the highest standard of care during and after pregnancy.
Experienced Specialists
Siliguri is home to several highly qualified and experienced fetal medicine specialists who have received training from premier medical institutes in India and abroad. These specialists have extensive experience in managing complex pregnancies and performing advanced fetal interventions, making them well-equipped to handle even the most challenging cases.
Comprehensive Maternal and Fetal Care
Fetal medicine specialists in Siliguri work in close collaboration with a range of healthcare professionals, including obstetricians, neonatologists, pediatric surgeons, and genetic counselors. This multidisciplinary approach ensures comprehensive care for both mother and baby, with specialists from various fields contributing to the management plan.
Personalized and Compassionate Care
Many fetal medicine centers in Siliguri prioritize personalized care, tailoring treatment plans to meet the specific needs of each patient. In addition to advanced medical treatments, these centers offer compassionate support and counseling, ensuring that expectant parents feel informed and supported throughout the pregnancy journey.
Cost-Effective Treatment
One of the advantages of seeking care in Siliguri is the relatively lower cost of medical treatments compared to metropolitan cities. Despite the availability of advanced medical technologies and expertise, patients can expect affordable care without compromising on quality.
Conditions Managed by Fetal Medicine Specialists in Siliguri
Fetal medicine specialists manage a wide range of conditions, ensuring both mother and baby receive appropriate care. Some of the common conditions they handle include:
Congenital Anomalies
These are structural or functional abnormalities that occur during fetal development. Early diagnosis through ultrasound and genetic testing can help in planning the appropriate course of treatment or intervention.
Intrauterine Growth Restriction (IUGR)
IUGR occurs when the fetus is not growing at the expected rate. A fetal medicine specialist will closely monitor the fetus's growth and take necessary steps to manage the condition.
Multiple Pregnancies
Carrying twins, triplets, or more can increase the risk of complications. Fetal medicine specialists in Siliguri offer specialized care for mothers expecting multiple babies, reducing the risk of preterm labor, TTTS, and other complications.
Preterm Labor
Preterm labor refers to labor that begins before the 37th week of pregnancy. Fetal medicine specialists work to prevent and manage preterm labor through medications, lifestyle adjustments, and other interventions.
Rh Incompatibility
When the mother's blood type is Rh-negative and the fetus's blood type is Rh-positive, Rh incompatibility can occur, leading to serious complications. Fetal medicine specialists closely monitor and manage this condition through appropriate treatments, such as intrauterine blood transfusions.
Gestational Diabetes and Hypertension
Pregnancy can sometimes lead to conditions like gestational diabetes or pregnancy-induced hypertension, which can pose risks to both the mother and the fetus. Fetal medicine specialists offer careful monitoring and management of these conditions to minimize risks.
How to Choose the Right Fetal Medicine Specialist in Siliguri
Choosing the right fetal medicine specialist is crucial for ensuring a healthy pregnancy and delivery. Here are some factors to consider when selecting a specialist in Siliguri:
Experience and Qualifications: Ensure the specialist has the necessary qualifications, including advanced training in fetal medicine, and has experience handling high-risk pregnancies.
Reputation and Reviews: Look for reviews or testimonials from other patients to gauge the specialist's reputation.
Hospital Facilities: Check if the hospital or clinic is well-equipped with modern diagnostic tools and NICU facilities.
Accessibility and Availability: It’s essential to choose a specialist who is easily accessible and available for regular follow-ups, especially in case of emergencies.
Conclusion
Fetal medicine is a crucial field in modern obstetrics, offering vital services to ensure the health and well-being of both mother and baby during pregnancy. For expectant parents in and around Siliguri, the availability of experienced fetal medicine specialists provides access to world-class care without the need to travel to larger cities. With a combination of advanced technology, expert knowledge, and personalized care, Siliguri is becoming a trusted destination for maternal and fetal healthcare.
If you're looking for a fetal medicine specialist in Siliguri, be sure to choose a professional who is experienced, compassionate, and equipped with the latest tools to ensure a safe and healthy pregnancy journey.
0 notes
Text
CVS Blood Test for Early Pregnancy Detection
The CVS blood pregnancy test, also known as Chorionic Villus Sampling, is a prenatal test performed to detect genetic abnormalities in the fetus. Conducted between 10 and 13 weeks of pregnancy, this test analyzes a small sample of placental tissue. It provides early and accurate insights into the baby’s genetic health, helping parents make informed decisions during pregnancy.
0 notes